These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36533708)

  • 1. Development of eplerenone nano sono-crystals using factorial design: enhanced solubility and dissolution rate via anti solvent crystallization technique.
    Yassin GE; Khalifa MKA
    Drug Dev Ind Pharm; 2022 Dec; 48(12):683-693. PubMed ID: 36533708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability.
    Khan MA; Ansari MM; Arif ST; Raza A; Choi HI; Lim CW; Noh HY; Noh JS; Akram S; Nawaz HA; Ammad M; Alamro AA; Alghamdi AA; Kim JK; Zeb A
    Drug Deliv; 2021 Dec; 28(1):2510-2524. PubMed ID: 34842018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
    Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X
    Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Solubility and Dissolution Rate of Lacidipine Nanosuspension: Formulation Via Antisolvent Sonoprecipitation Technique and Optimization Using Box-Behnken Design.
    Kassem MAA; ElMeshad AN; Fares AR
    AAPS PharmSciTech; 2017 May; 18(4):983-996. PubMed ID: 27506564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.
    Ibrahim AH; Smått JH; Govardhanam NP; Ibrahim HM; Ismael HR; Afouna MI; Samy AM; Rosenholm JM
    Eur J Pharm Sci; 2020 Jan; 142():105103. PubMed ID: 31648050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etoposide Amorphous Nanopowder for Improved Oral Bioavailability: Formulation Development, Optimization, in vitro and in vivo Evaluation.
    Wang Y; Wang S; Xu Y; Wang P; Li S; Liu L; Liu M; Jin X
    Int J Nanomedicine; 2020; 15():7601-7613. PubMed ID: 33116490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocrystalization of Pioglitazone by Precipitation Method.
    Varshosaz J; Ahmadipour S; Tabbakhian M; Ahmadipour S
    Drug Res (Stuttg); 2018 Oct; 68(10):576-583. PubMed ID: 29631296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology.
    Gajera BY; Shah DA; Dave RH
    Int J Pharm; 2019 Mar; 559():348-359. PubMed ID: 30721724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization, in-vitro Release and in-vivo Evaluation of Gliquidone Nanoparticles.
    Mohamed MS; Abdelhafez WA; Zayed G; Samy AM
    AAPS PharmSciTech; 2019 Dec; 21(2):35. PubMed ID: 31879830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro dissolution enhancement of micronized l-nimodipine by antisolvent re-crystallization from its crystal form H.
    Zu Y; Li N; Zhao X; Li Y; Ge Y; Wang W; Wang K; Liu Y
    Int J Pharm; 2014 Apr; 464(1-2):1-9. PubMed ID: 24456674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
    Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the Impact of Multi-factorial Composition on Efficient Loading of the Stable Ketoprofen Nanoparticles on Orodispersible Films Using Box-Behnken Design.
    Shah HG; Rathod V; Basim P; Gajera B; Dave RH
    J Pharm Sci; 2022 May; 111(5):1451-1462. PubMed ID: 34678275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and characterization of microcrystals for enhanced dissolution rate of celecoxib.
    Lakshmi K; Reddy MP; Kaza R
    Curr Drug Discov Technol; 2013 Dec; 10(4):305-14. PubMed ID: 24074306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality by Design-Based Crystallization of Curcumin Using Liquid Antisolvent Precipitation: Micromeritic, Biopharmaceutical, and Stability Aspects.
    Som S; Singh SK; Khatik GL; Kapoor B; Gulati M; Kuppusamy G; Anandhakrishnan NK; Kumar B; Yadav AK; Kumar R; Singh PK; Khursheed R; Kumar R; Pandey NK; Jyoti J; Mohanta S; Porwal O
    Assay Drug Dev Technol; 2020 Jan; 18(1):11-33. PubMed ID: 31268345
    [No Abstract]   [Full Text] [Related]  

  • 15. Preparation and characterization of betulin nanoparticles for oral hypoglycemic drug by antisolvent precipitation.
    Zhao X; Wang W; Zu Y; Zhang Y; Li Y; Sun W; Shan C; Ge Y
    Drug Deliv; 2014 Sep; 21(6):467-79. PubMed ID: 24479653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of high pressure homogenization on physicochemical properties of curcumin nanoparticles prepared by antisolvent crystallization using HPMC or PVP.
    Homayouni A; Sohrabi M; Amini M; Varshosaz J; Nokhodchi A
    Mater Sci Eng C Mater Biol Appl; 2019 May; 98():185-196. PubMed ID: 30813018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
    Jain S; Reddy VA; Arora S; Patel K
    Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Theory and practice of electrospray crystallization in particle size reduction].
    Szunyogh T; Ambrus R; Szabóné Révész P
    Acta Pharm Hung; 2015; 85(2):43-50. PubMed ID: 26390735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promising dissolution enhancement effect of soluplus on crystallized celecoxib obtained through antisolvent precipitation and high pressure homogenization techniques.
    Homayouni A; Sadeghi F; Varshosaz J; Afrasiabi Garekani H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2014 Oct; 122():591-600. PubMed ID: 25124835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
    Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
    J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.